Vietnam’s Nutifood Advances Global Nutrition Ambitions With USPTO Patent
Photo Courtesy: Nutifood (Mr. Tran Bao Minh, Vice Chairman of Nutifood, emphasized the significance of Nutifood being granted the patent.)

Vietnam’s Nutifood Advances Global Nutrition Ambitions With USPTO Patent

By: Ethan Lee

A newly granted USPTO patent is strengthening Nutifood’s push into the global premium nutrition market.

Nutifood has secured United States Patent and Trademark Office protection for its proprietary pediatric nutrition formula. The patent marks a notable development for Vietnamese manufacturers seeking international intellectual property recognition.

U.S. Expansion Targets Premium Segment

The USPTO granted patent approval for Nutifood’s FDI Formula, a formulation combining 2′-FL HMO, a human milk oligosaccharide, with FOS prebiotic fiber in a proprietary ratio designed to help support digestive and immune health in young children.

Developed by the Nutifood Nutrition Research Institute in Sweden, the formula underwent clinical evaluation by Vietnam’s National Institute of Nutrition in 2021. The study found improvements in common pediatric digestive issues, including loss of appetite, constipation, and diarrhea, alongside a potential reduction in respiratory infection risk.

“Nutifood FDI Formula being granted a patent by the USPTO is evidence of Nutifood’s serious commitment to investing in nutritional science research,” said Tran Bao Minh, Vice Chairman of Nutifood.

Concurrent with the patent announcement, Nutifood unveiled Nutifood America-Nutrition Science, a new U.S.-based operation signaling international expansion. The initiative includes expanding A2 Organic dairy farming in the United States. Nutifood is also evaluating investment in spray-drying facilities to supply premium A2 ingredients back to Vietnam for manufacturing under the new brand.

Meanwhile, Mr. Glenn Millar, Executive Vice President of Strategy and Global Markets, California Milk Advisory Board, noted that the USPTO-patented FDI Formula provides a strong foundation for Nutifood to further develop specialized nutritional solutions aligned with international standards.

International Research Infrastructure

The USPTO patent comes as Nutifood continues to expand its international research and manufacturing footprint to compete in the rapidly growing premium nutrition segment.

Over the past five years, the company’s proprietary FDI Formula has been integrated across its GrowPLUS+ portfolio, helping strengthen Nutifood’s position in Vietnam’s pediatric nutrition market. Building on that foundation, the company has expanded its R&D ecosystem across Sweden and Australia while developing partnerships with global ingredient suppliers including BASF, DuPont, and DSM-Firmenich. Nutifood also operates manufacturing facilities in Vietnam, Sweden, and Australia.

The strategy aligns with broader industry trends. According to IMARC Group, the Asia-Pacific dairy market, valued at $361.7 billion in 2025, is projected to reach $605.4 billion by 2034. As demand for premium nutrition accelerates, Nutifood has focused on international partnerships to strengthen access to advanced dairy expertise and high-quality ingredient sourcing. In 2025, the company partnered with ViPlus Dairy, a 130-year-old dairy company from Australia’s Gippsland region, to launch the premium dairy brand GippsNature.

Photo Courtesy: Nutifood (Nutifood has taken decisive steps toward globalisation.)

Against that backdrop, the USPTO patent provides Nutifood with both scientific credibility and legal protection as the company continues pursuing international expansion opportunities.

Disclaimer: This article is for informational purposes only and should not be considered medical or nutritional advice. Product-related statements should not be interpreted as claims to diagnose, treat, cure, or prevent any disease. Parents and caregivers should consult a qualified healthcare professional before making nutrition decisions for children. Market figures, projections, and growth estimates cited in this article are based on third-party research and available data at the time of publication. Actual results, market conditions, and business outcomes may vary.

This article features branded content from a third party. Opinions in this article do not reflect the opinions and beliefs of New York Weekly.